SUBSTANTIAL VARIATION IN THE PRICES OF DRUGS USED IN COST-EFFECTIVENESS ANALYSES OF NOVEL ORAL ANTI-COAGULANTS

被引：0
作者：
Sacks, Chana A. [1 ]
Kesselheim, Aaron [1 ]
Fralick, Michael [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
[31]   USE OF NOVEL AND SOCIAL ELEMENTS OF VALUE IN COST-EFFECTIVENESS ANALYSES [J].
Crummer, E. ;
Cohen, J. ;
Neumann, P. ;
Kim, D. .
VALUE IN HEALTH, 2023, 26 (06) :S141-S141
[32]   The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses [J].
Hettiarachchi, Ruvini M. ;
Kularatna, Sanjeewa ;
Downes, Martin J. ;
Byrnes, Joshua ;
Kroon, Jeroen ;
Lalloo, Ratilal ;
Johnson, Newell W. ;
Scuffham, Paul A. .
COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2018, 46 (02) :118-124
[33]   COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES [J].
Tervonen, T. ;
Ustyugova, A., V ;
Lip, G. ;
Verdecchia, P. ;
Bhashyam, Sri S. ;
Heinrich-Nols, J. ;
Gropper, S. ;
Kwan, R. ;
Marsh, K. .
VALUE IN HEALTH, 2016, 19 (07) :A349-A349
[34]   A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures [J].
L. Si ;
T. M. Winzenberg ;
A. J. Palmer .
Osteoporosis International, 2014, 25 :51-60
[35]   A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures [J].
Si, L. ;
Winzenberg, T. M. ;
Palmer, A. J. .
OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) :51-60
[36]   A SYSTEMATIC REVIEW OF THE USE OF PRODUCTIVITY LOSS/GAIN IN COST-EFFECTIVENESS ANALYSES FOR DRUGS [J].
Yuasa, A. ;
Yonemoto, N. ;
LoPresti, M. ;
Ikeda, S. .
VALUE IN HEALTH, 2020, 23 :S614-S614
[37]   COST-EFFECTIVENESS AND COST-BENEFIT ANALYSES IN THE MEDICAL LITERATURE - ARE THE METHODS BEING USED CORRECTLY [J].
UDVARHELYI, IS ;
COLDITZ, GA ;
RAI, A ;
EPSTEIN, AM .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (03) :238-244
[38]   Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs : A Systematic Review [J].
Zhao, Mingye ;
Shao, Taihang ;
Yin, Yue ;
Fang, Hongshu ;
Shao, Hanqiao ;
Tang, Wenxi .
JAMA NETWORK OPEN, 2025, 8 (05)
[39]   Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review [J].
Akira Yuasa ;
Naohiro Yonemoto ;
Michael LoPresti ;
Shunya Ikeda .
PharmacoEconomics, 2021, 39 :81-97
[40]   Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses [J].
Hoyle, Martin .
VALUE IN HEALTH, 2010, 13 (08) :885-892
12345